Moreover, our study demonstrated that COVID-19 patients (76%) had a greater prevalence of the CC genotype of the TMPRSS2 p.Val197Met variation than did the control group (66%) and was also higher in all patient groups compared to CT and TT. The gene discussed is TMPRSS2; the disease is COVID-19.